# Dysplastic Megakaryocytes in a Gallbladder Neck Lymph Node in a Patient With Essential Thrombocythemia: A Case Report

**Authors:** Mahi Balcı

PMC · DOI: 10.1155/crh/5591025 · Case Reports in Hematology · 2026-03-05

## TL;DR

A patient with essential thrombocythemia had a rare lymph node finding with abnormal megakaryocytes, highlighting the need to consider blood cancers in lymph node cases.

## Contribution

This case report documents a rare lymph node involvement by dysplastic megakaryocytes in essential thrombocythemia.

## Key findings

- A lymph node in the gallbladder neck contained atypical megakaryocytes with multinucleation and nuclear lobulation.
- Immunohistochemistry confirmed megakaryocytic origin with CD61 and Factor VIII positivity.
- The findings ruled out metastatic carcinoma or lymphoma and highlighted hematologic malignancy considerations.

## Abstract

A woman in her 60s with a known history of JAK2‐positive essential thrombocythemia presented with a one‐week history of jaundice. Laboratory testing revealed elevated bilirubin and alkaline phosphatase levels. Abdominal ultrasonography identified a 1‐cm gallstone, and laparoscopic cholecystectomy was performed. Histopathological evaluation revealed chronic cholecystitis along with a 5‐mm lymph node in the gallbladder neck harboring atypical megakaryocytes with multinucleation and nuclear lobulation. Immunohistochemistry confirmed megakaryocytic origin with strong positivity for CD61 and supportive positivity for Factor VIII, while epithelial and lymphoid markers were negative, ruling out metastatic carcinoma or lymphoma. This case underscores the rare involvement of lymph nodes by dysplastic megakaryocytes in essential thrombocythemia and highlights the importance of considering hematologic malignancies in the differential diagnosis of lymphadenopathy.

## Linked entities

- **Proteins:** ITGB3 (integrin subunit beta 3)
- **Diseases:** essential thrombocythemia (MONDO:0005029), chronic cholecystitis (MONDO:0002155)

## Full-text entities

- **Genes:** CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, MPL (MPL proto-oncogene, thrombopoietin receptor) [NCBI Gene 4352] {aka C-MPL, CD110, MPLV, THCYT2, THPOR, TPOR}, CD34 (CD34 molecule) [NCBI Gene 947], KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, MFSD11 (major facilitator superfamily domain containing 11) [NCBI Gene 79157] {aka ET}, ITGB3 (integrin subunit beta 3) [NCBI Gene 3690] {aka BDPLT16, BDPLT2, BDPLT24, CD61, FMAIT1, GP3A}, GP1BA (glycoprotein Ib platelet subunit alpha) [NCBI Gene 2811] {aka BDPLT1, BDPLT3, BSS, CD42B, CD42b-alpha, DBPLT3}, S1PR1 (sphingosine-1-phosphate receptor 1) [NCBI Gene 1901] {aka CD363, CHEDG1, D1S3362, ECGF1, EDG-1, EDG1}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, FUT4 (fucosyltransferase 4) [NCBI Gene 2526] {aka CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX}, CALR (calreticulin) [NCBI Gene 811] {aka CALR1, CRT, HEL-S-99n, RO, SSA, cC1qR}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943] {aka CD30, D1S166E, Ki-1}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}
- **Diseases:** Splenomegaly (MESH:D013163), Lymphadenopathy (MESH:D008206), primary myelofibrosis (MESH:D055728), cholecystitis (MESH:D002764), jaundice (MESH:D007565), Hodgkin lymphoma (MESH:D006689), sarcoma (MESH:D012509), hematologic malignancies (MESH:D019337), -EMH (MESH:C536227), Chronic inflammation (MESH:D007249), gallstone (MESH:D042882), MPN (MESH:D009369), polycythemia vera (MESH:D011087), epithelial malignancies (MESH:D002277), metastatic (MESH:D000092182), Thrombocythemia (MESH:D013922), lymphoma (MESH:D008223), lymphomatous (MESH:D013967), pancreaticobiliary or gastrointestinal tumors (MESH:D005770), ET (MESH:D013920), oncologic (MESH:D000072716), thrombotic (MESH:D013927), hepatomegaly (MESH:D006529), hematologic disorders (MESH:D006402), leukemic transformation (MESH:D002472)
- **Chemicals:** bilirubin (MESH:D001663)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12963451/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12963451/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12963451/full.md

---
Source: https://tomesphere.com/paper/PMC12963451